The effect of HIGD2A high expression level on DLBCL patient survival illustrates a downward trend of survival probability in patients (n = 11) with high expression in relation with patients (n = 36) with low expression, p = 0.85 [49] (Figure 8). The gene discussed is HIGD2A; the disease is diffuse large B-cell lymphoma.